Barclays’s Lumexa Imaging Holdings LMRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$813K Buy
79,330
+75,934
+2,236% +$863K ﹤0.01% 3189
2026
Q2
$38.3K Sell
3,396
-13,451
-80% -$123K ﹤0.01% 4402
2026
Q1
$145K Buy
16,847
+9,647
+134% +$132K ﹤0.01% 3858
2025
Q4
$133K Buy
+7,200
New +$130K ﹤0.01% 4489

Other funds holding LMRI

Barclays's LMRI Position: Q3 2026 in Review

Barclays increased its Lumexa Imaging Holdings (LMRI) stake by 2,236% in Q3 2026, buying an estimated $863K and bringing the position to 79,330 shares worth $813K. The position accounts for ﹤0.01% of the portfolio, ranked #3189.

Barclays first reported a position in LMRI in Q4 2025 and has held it in 4 quarters since. 44 funds tracked by Wall St. Rank hold LMRI as of Q3 2026.

  • Barclays held 79,330 shares of Lumexa Imaging Holdings worth $813K as of Q3 2026.
  • Barclays bought 75,934 Lumexa Imaging Holdings shares in Q3 2026, an estimated $863K.
  • Lumexa Imaging Holdings made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3189 holding.
  • Barclays first reported a position in Lumexa Imaging Holdings in Q4 2025 and has held it in 4 quarters since.
  • 44 funds tracked by Wall St. Rank held Lumexa Imaging Holdings as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.